
Archimed Capital research hub
| Platform | Pricing | Only free issues | Publishes | Weekly | |
|---|---|---|---|---|---|
| Issues | 127 | Founded | 3 years ago | Last Issue | 9 days ago |
| Active | |||||

Last week was not a pullback. It was a liquidation.
Total crypto market cap fell 12.8%. BTC was down 13.7%, ETH down 19.3%, and SOL down 20.8%. Total market cap now sits around $2.11T, down 52% from the October ATH and 30% from the 2021 AT...
Crypto had another week where the headline price action said less than the plumbing underneath. BTC traded heavy, ETH continued to look like the complex’s weak duration leg, and SOL remained the cleaner expression of tactical beta. That par...
Crypto spent the week under pressure, but the cross-sectional message improved. BTC saw roughly a 5% peak-to-trough drawdown before finishing about 2% lower on the week; ETH was the laggard, while SOL held up best. The deeper point is that...
Crypto entered the week under pressure, but the market held where it needed to.
BTC struggled to build momentum, alts lagged, yields moved higher, and Fed pricing shifted further hawkish. In that context, Bitcoin’s ability to defend the sa...
In last weeks, The Insider, we argued that BTC needed a daily and weekly close above $78,000 to confirm acceptance above the range, and that $80,000 was the next trigger which could then open a move into the mid-$80,000s. That was the core...
Subscribers, engagement, traffic and sponsorship for Archimed Capital.
| Subscribers | Engagement | 64 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #207 |
The writers behind this newsletter.
Research @ Archimed Capital
Backing Web3 Builders
You can find recent issues that have been published by Archimed Capital on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Archimed Capital, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Archimed Capital as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Archimed Capital using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Archimed Capital. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.